Barriers and solutions to addressing tobacco dependence in addiction treatment programs

Douglas M Ziedonis, Joseph Guydish, Jill Williams, Marc Steinberg, Jonathan Foulds, Douglas M Ziedonis, Joseph Guydish, Jill Williams, Marc Steinberg, Jonathan Foulds

Abstract

Despite the high prevalence of tobacco use among people with substance use disorders, tobacco dependence is often overlooked in addiction treatment programs. Several studies and a meta-analytic review have concluded that patients who receive tobacco dependence treatment during addiction treatment have better overall substance abuse treatment outcomes compared with those who do not. Barriers that contribute to the lack of attention given to this important problem include staff attitudes about and use of tobacco, lack of adequate staff training to address tobacco use, unfounded fears among treatment staff and administration regarding tobacco policies, and limited tobacco dependence treatment resources. Specific clinical-, program-, and system-level changes are recommended to fully address the problem of tobacco use among alcohol and other drug abuse patients.

Conflict of interest statement

Financial Disclosure

The authors declare that they have no competing financial interests.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6527042/bin/228-235f1.jpg
Comparative causes of annual deaths in the United States. Tobacco use is the number one preventable cause of death in the United States. SOURCE: Centers for Disease Control and Prevention (CDC), 2001. Available at: www.cdc.gov/tobacco/research_data/health_consequences/andths.htm

References

    1. American Psychiatric Association (APA) Substance Use Disorder Practice Guidelines. Washington, D.C.: American Psychiartic Publishing Press; 2006.
    1. Asher MK, Martin RA, Rohsenow DJ, et al. Perceived barriers to quitting smoking among alcohol dependent patients in treatment. Journal of Substance Abuse Treatment. 2003;24:169–174.
    1. Bernstein SM, Stoduto G. Adding a choice-based program for tobacco smoking to an abstinence-based addiction treatment program. Journal of Substance Abuse Treatment. 1999;17:167–173.
    1. Bierut LJ, Rice JP, Goate A, et al. A genomic scan for habitual smoking in families of alcoholics: Common and specific genetic factors in substance dependence. American Journal of Medical Genetics Part A. 2004;124:19–27.
    1. Bobo JK, Davis CM. Recovering staff and smoking in chemical dependency programs in rural Nebraska. Journal of Substance Abuse Treatment. 1993;10:221–227.
    1. Centers for Disease Control and Prevention (CDC) State specific prevalence of cigarette smoking and quitting among adults–United States, 2005. Morbidity and Mortality Weekly Report (MMWR) 2005 Nov 11;54:1124–1127.
    1. Centers for Disease Control and Prevention (CDC), National Center for Chronic Disease Prevention and Health Promotion, Tobacco Information and Prevention Source (TIPS) Comparative Causes of Annual Deaths in the United States, 2001. Available at: .
    1. Goldstein MG, DePue JD, Monroe AD, et al. A population-based survey of physician smoking cessation counseling practices. Preventive Medicine. 1998;27:720–729.
    1. Hammond D, Fong GT, Zanna MP, et al. Tobacco denormalization and industry beliefs among smokers from four countries. American Journal of Preventive Medicine. 2006;31:225–232.
    1. Hoffman AL, Slade J. Following the pioneers: Addressing tobacco in chemical dependency treatment. Journal of Substance Abuse Treatment. 1993;10:153–160.
    1. Hurt RD, Croghan I, Offord KP, et al. Attitudes toward nicotine dependence among chemical dependency unit staff: Before and after a smoking cessation trial. Journal of Substance Abuse Treatment. 1995;12:247–252.
    1. Hurt RD, Offord KP, Croghan IT, et al. Mortality following inpatient addictions treatment. Journal of the American Medical Association: JAMA. 1996;275:1097–1103.
    1. Joseph AM, Willenbring ML, Nelson D, et al. Timing of alcohol and smoking cessation study. Alcoholism: Clinical and Experimental Research. 2002;26:1945–1946.
    1. Joseph AM, Willenbring ML, Nugent SM, Nelson DB. A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment. Journal of Studies on Alcohol. 2004;65(6):681–691.
    1. Kozlowski LT, Wilkinson A, Skinner W, et al. Comparing tobacco cigarette dependence with other drug dependencies: Greater or equal “difficulty quitting” and “urges to use” but less pleasure from cigarettes. Journal of the American Medical Association. 1989;61:898–901.
    1. Lasser K, Wesley BJ, Woolhandler S, et al. Smoking and mental illness: A population-based prevalence study. Journal of the American Medical Association: JAMA. 2000;284:2606–2610.
    1. National Association of Alcoholism and Drug Abuse Counselors (NAADAC) Nicotine Dependence, 2006. Position Statement. Available at: .
    1. Order-Connors B. Smoke screen. Professional Counselor. 1996;11(6):15–52.
    1. Prochaska JK, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of Consulting and Clinical Psychology. 2004;72:1144–1156.
    1. Richter KP, Choi WS, Alford DP. Smoking policies in U.S. outpatient drug treatment facilities. Nicotine and Tobacco Research. 2005;7:475–480.
    1. Steinberg ML, Ziedonis DM, Krejci JA, et al. Motivational interviewing with personalized feedback: A brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. Journal of Consulting and Clinical Psychology. 2004;72:723–728.
    1. Stuyt EB, Order-Connors B, Ziedonis DM. Addressing tobacco through program and system change in mental health and addiction settings. Psychiatric Annals. 2003;33:446–456.
    1. Sussman S. Smoking cessation among persons in recovery. Substance Use & Misuse. 2002;37:1275–1298.
    1. Thrasher JF, Niederdeppe J, Farrelly MC, et al. The impact of anti-tobacco industry prevention messages in tobacco producing regions: Evidence from the US truth campaign. Tobacco Control. 2004;13(3):283–238.
    1. Tobacco Free Oregon. Make It your Business: Insure a Tobacco-Free Workforce, 2003. [Accessed May 8, 2005]. Available at: .
    1. True WR, Xian H, Scherrer JF, et al. Common genetic vulnerability for nicotine and alcohol dependence in men. Archives of General Psychiatry. 1999;56:655–661.
    1. U.S. Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006.
    1. Williams JM, Foulds J, Dwyer M, et al. The integration of tobacco dependence treatment into residential addictions treatment in New Jersey. Journal of Substance Abuse Treatment. 2005;28:331–340.
    1. Ziedonis D, Williams J. Management of smoking in people with psychiatric disorders. Current Opinion in Psychiatry. 2003;16:305–315.
    1. Ziedonis D, Williams JM, Steinberg M, et al. Addressing tobacco addiction in office-based management of psychiatric disorders: Practical considerations. Primary Psychiatry. 2006;13:51–63.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir